- Fund Type: ETF
- Objective: Health Care
- Asset Class: Equity
- Geographic Focus: U.S.
iShares Nasdaq Biotechnology ETF
+ Add to WatchlistIBB:US
209.7900 USD 3.3900 1.59%As of 13:26:01 ET on 10/03/2013.
Snapshot for iShares Nasdaq Biotechnology ETF (IBB)
| Open: | 213.3000 | High - Low: | 213.4211 - 207.9000 | Primary Exchange: | NASDAQ GM |
|---|---|---|---|---|---|
| Volume: | 549,017 | 52-Week Range: | 125.6300 - 213.7800 | Beta vs NBI: | 1.0046 |
Fund Profile & Information for IBB
iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.
| Inception Date: | 2001-02-09 | Telephone: | 1-415-670-2000 |
|---|---|---|---|
| Managers: | GREG SAVAGE | ||
| Web Site: | www.ishares.com | ||
Fundamentals for IBB
| NAV | (on 2013-10-02) 212.9800 |
|---|---|
| Assets (M) | (on 2013-10-02) 4,248.8720 |
| Shares out (M) | 19.95 |
| Market Cap (M) | 4,220.82 |
| % Premium | 0.09 |
| Average 52-Week % Premium | 0.0078 |
| Fund Leveraged | N |
Dividends for IBB
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | - |
| Dividend Yield (ttm) | 0.08% |
Performance for IBB
| 1-Month | +10.03% | 1-Year | +47.01% |
|---|---|---|---|
| 3-Month | +19.19% | 3-Year | +35.36% |
| Year To Date | +55.42% | 5-Year | +22.59% |
| Expense Ratio | 0.48 |
Top Fund Holdings for IBB
Filing Date: 10/01/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Biogen Idec Inc | 1,395,183 | 341,708,220 | 8.508% |
| Celgene Corp | 2,125,613 | 334,146,364 | 8.320% |
| Regeneron Pharmaceuticals Inc | 1,000,328 | 316,833,887 | 7.889% |
| Amgen Inc | 2,730,614 | 312,873,752 | 7.790% |
| Gilead Sciences Inc | 4,936,223 | 309,994,804 | 7.718% |
| Mylan Inc/PA | 4,161,972 | 164,189,795 | 4.088% |
| Alexion Pharmaceuticals Inc | 1,380,404 | 162,045,626 | 4.035% |
| Vertex Pharmaceuticals Inc | 1,977,768 | 152,327,691 | 3.793% |
| BioMarin Pharmaceutical Inc | 1,527,181 | 115,974,125 | 2.888% |
| Illumina Inc | 1,363,860 | 110,731,793 | 2.757% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page